Listened to this today...several things caught my attention...positives being..the stuff they are working on that at this stage they want to keep in house...I’d assume these are the better ones....the presenter came across as a straight up and down type..although not that articulate ..a small thing ..and a bit of a negative for me was that he seemed to be splitting hairs a bit with tick results from the French co that dumped it that Krannert is testing further...it seems it doesn’t work without modification.
Ann: Bio-Gene Investor Conference Call - 26 March 2018, page-6
Add BGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.859M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 100510 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 12495 | 1 |
View Market Depth
| Last trade - 10.40am 04/12/2024 (20 minute delay) ? |
| BGT (ASX) Chart |
Day chart unavailable
